Sudden coma at the onset of severe refractory thrombotic thrombocytopenic purpura with successful treatment

被引:0
|
作者
Xu, Jingyuan [1 ]
Guan, Jiaheng [2 ]
Li, Qing [1 ]
Qian, Jie [3 ]
Wang, Yuancheng [4 ]
Huang, Yingzi [1 ]
Chen, Baoan [2 ]
Yang, Yi [1 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med,Jiangsu Prov Key Lab Crit Care, Nanjing 210009, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Sch Med, Dept Hematol & Oncol, Nanjing 210009, Peoples R China
[3] Suqian First Hosp, Dept Crit Care Med, Suqian 223800, Peoples R China
[4] Southeast Univ, Zhongda Hosp, Sch Med, Dept Radiol, Nanjing 210009, Peoples R China
关键词
Coma; Thrombotic thrombocytopenic purpura; Plasma exchange; TTP;
D O I
10.1016/j.transci.2021.103225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most patients develop coma several days after the onset of thrombotic thrombocytopenic purpura (TTP) caused by microvascular occlusion. However, aggravated coma as the first symptom of TTP has rarely been reported. Although plasma exchange (PEX) and steroids have reduced mortality, the prognosis of patients with TTP is still poor. We reported a patient with refractory TTP presenting with aggravated coma on admission. After days of successful PEX, rituximab, and glucocorticoid therapy for clinical remission, the patient regained consciousness and returned to his normal life with a good outcome. Our case highlights that TTP should be considered when coma occurs as the first symptom.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Mycophenolate mofetil for treatment of relapsed, refractory thrombotic thrombocytopenic purpura
    Wang, A.
    Wu, J.
    Ding, K.
    Liu, X.
    Sun, Z.
    Su, J.
    Yu, Z.
    Ruan, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1177 - 1177
  • [32] Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption
    Gaddis, TG
    Guthrie, TH
    Drew, MJ
    Sahud, M
    Howe, RB
    Mittelman, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 55 (02) : 55 - 58
  • [33] Cyclophosphamide and prednisone for the treatment of refractory thrombotic thrombocytopenic purpura.
    Morgensztern, D
    Kharfan-Dabaja, MA
    Thompson, PL
    Puzis, L
    Lian, EC
    BLOOD, 2001, 98 (11) : 62B - 62B
  • [34] SUCCESSFUL TREATMENT OF RECURRENT THROMBOTIC THROMBOCYTOPENIC PURPURA WITH PLASMAPHERESIS AND VINCRISTINE
    VANGOOL, S
    BROCK, P
    VANLAER, P
    VANDAMMELOMBAERTS, R
    PROESMANS, W
    CASTEELSVANDAELE, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (07) : 517 - 519
  • [35] Thrombotic microangiopathy during intensive care - Treatment of refractory thrombotic thrombocytopenic purpura
    Mariotte, E.
    Azoulay, E.
    REANIMATION, 2011, 20 (02): : S338 - S344
  • [36] THROMBOTIC THROMBOCYTOPENIC PURPURA - SUCCESSFUL TREATMENT UNLOCKS ETIOLOGIC SECRETS
    SCHMIDT, JL
    MAYO CLINIC PROCEEDINGS, 1989, 64 (08) : 956 - 961
  • [37] Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab
    Sankararaman, Senthilkumar
    Jeroudi, Majed
    Ibrahim, Hassan
    PEDIATRICS INTERNATIONAL, 2014, 56 (06) : 914 - 918
  • [38] Successful treatment with rituximab of refractory immune thrombocytopenic purpura
    Tirotta, Daniela
    Durante, Vittorio
    CLINICAL MANAGEMENT ISSUES, 2009, 3 (04) : 171 - 179
  • [39] Rituximab for the treatment of relapsing/refractory thrombotic thrombocytopenic purpura (TTP).
    Ahmad, A
    Aggarwal, A
    Sharma, D
    Kinsella, V
    Dave, HP
    Schechter, GP
    Rick, ME
    BLOOD, 2002, 100 (11) : 686A - 686A
  • [40] Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)
    Ahmad, A
    Aggarwal, A
    Sharma, D
    Dave, HP
    Kinsella, V
    Rick, ME
    Schechter, GP
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (02) : 171 - 176